IP Library Granted Patent US 12702856
Granted Patent B2
US 12702856 · App. 18/506,954 · Granted Aug 11, 2026

Apparatus and method for controlling immunostimulating laser thermotherapy

Inventors: Karl-Göran Tranberg (Lund, SE); Stephan Dymling (Lund, SE)
Assignee: Clinical Laserthermia Systems AB
A61N5/0601A61B2018/00023A61B2018/00642A61B2018/00678A61B2018/00702A61B2018/00797A61B2018/00898A61B2018/2005A61B2018/20361A61B2018/2261A61N2005/0612A61N2005/0626A61N2005/0627A61N2005/063A61N2005/0659A61N5/067
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12702856
App. No.
18/506,954
Granted
Aug 11, 2026
Kind
B2
Abstract

An apparatus for obtaining an anti-tumour immunologic response by thermotherapy of a treatment lesion covering at least a portion of a tumour is disclosed. The apparatus comprises a heating probe comprising an optical fiber and a cooling catheter. The optical fiber is inserted in the cooling catheter. Further the heating probe has a light emitting area, and the heating probe is interstitially insertable into the tumour of the treatment lesion. The heat probe is internally cooled by a fluid circulating in said catheter. The apparatus further comprises a first thermal sensor member having at least one sensor area. The first thermal sensor member is positionable at a distance from said boundary. The apparatus also comprises a control unit for controlling a power output of said light source based on a measured first temperature.

Claims (25)

1 . A computer-readable medium having embodied thereon a computer program for processing by a computer, the computer program is for thermotherapy of a predetermined treatment lesion covering at least a portion of a treatment lesion, and wherein said computer program comprising a plurality of code segments for:

obtaining at least one image of said treatment lesion and a laser-based heating probe arranged in said treatment lesion;

obtaining a first temperature of a first temperature area defined inside a boundary of said treatment lesion and adjacent to said laser-based heating probe, wherein said first temperature area is provided from a Magnetic Resonance Imaging (MRI);

monitoring, during a treatment period, said first temperature and switching off said laser-based heating probe, and/or providing a warning, should said first temperature exceed a defined maximal temperature.

2 . The computer readable medium according to claim 1 , comprising a code segment for obtaining a second temperature from said Magnetic Resonance Imaging (MRI) of a second temperature area defined outside of or at said boundary of said treatment lesion.

3 . The computer readable medium according to claim 2 , comprising a code segment for maintaining said second temperature at a target temperature by controlling a power to said laser-based heating probe, wherein predefined treatment lesion is obtained.

4 . The computer-readable medium according to claim 3 , comprises a code segment for providing a warning and/or switching of said laser-based heating probe if said target temperature is exceeded.

5 . The computer-readable medium according to claim 3 , wherein said controlling of said power to said laser-based heating is performed using a feedback control.

6 . The computer-readable medium according to claim 3 , wherein said target temperature is set to a range between 44 to 55° C.

7 . The computer-readable medium according to claim 6 , wherein said target temperature is set to provide an anti-treatment lesion immunologic response.

8 . The computer-readable medium according to claim 2 , wherein said second temperature area is arranged 2 to 7 mm outside said boundary of said treatment lesion.

9 . The computer readable medium according to claim 2 , wherein said second temperature is used for minimizing unpredictable tissue damage and lesion size to minimizing damage to healthy tissue.

10 . The computer-readable medium according to claim 1 , wherein a maximum temperature is set to a temperature below 120° C.

11 . The computer readable medium according to claim 1 , comprising a code segment for obtaining a third temperature from said Magnetic Resonance Imaging (MRI) of a third temperature area defined in adjacent to an organ at risk.

12 . The computer-readable medium according to claim 11 , comprises a code segment for providing a warning and/or switching of said laser-based heating probe if a maximum temperature of said third temperature is exceeded.

13 . The computer readable medium according to claim 11 , comprising a code segment wherein said third temperature is used in a feedback control to control said third temperature by adjusting said power of said laser-based heating probe to protect said organ at risk.

14 . The computer-readable medium according to claim 1 , wherein said laser-based heating probe has a diffusor arranged in said treatment lesion.

15 . The computer readable medium according to claim 14 , wherein said diffuser has a length between 5 to 30 mm.

16 . The computer-readable medium according to claim 1 , comprising a code segment for performing an initial warm-up period.

17 . The computer readable medium according to claim 1 , wherein said treatment lesion has the same size as a tumour to be treated.

18 . The computer readable medium according to claim 1 , comprising a code segment to run a treatment for a pre-defined period of time.

19 . The computer readable medium according to claim 1 , wherein said laser-based heating probe uses a wavelength with an absorption wavelength in visual or near infrared wavelength region.

20 . The computer readable medium according to claim 19 , wherein said wavelength region is 700 to 1300 nm.

21 . The computer readable medium according to claim 1 , wherein said first temperature is used for minimizing evaporisation and carbonization of tissue in said treatment lesion.

22 . The computer readable medium according to claim 1 , wherein said first temperature is used for minimising unpredictable tissue damage.